LIFE-VENUS Study

国立健康危機管理研究機構チームによる論文がIJID Regionsにアクセプトされました：Mimura W, Ishiguro C*, Maeda M, Oda F, Fukuda H. Shortage of Japanese encephalitis vaccine and vaccination coverage in three municipalities in Japan: the VENUS Study. IJID Regions 2026; in press.

国立健康危機管理研究機構臨床研究センターチームによる論文がClinical Microbiology and Infectionにアクセプトされました：Mimura W, Ishiguro C*, Shimizu Y, Terada-Hirashima J, Maeda M, Oda F, Fukuda H. Assessment of Timing for Influenza Vaccination among Older Adults in Japan: The VENUS Study. Clinical Microbiology and Infection 2026; in press.

九州大学・福田チームの論文が Journal of Epidemiologyにアクセプトされました：Maeda M, Oda F, Kitamura T, Fukuda H*. Association between influenza vaccination and ischemic stroke risk in a population-based nested case-control study: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study. Journal of Epidemiology 2026; in press.

国立健康危機管理研究機構臨床研究センターチームによる論文がHuman Vaccines & Immunotherapeuticsにアクセプトされました：Ishiguro C*, Morita H, Mimura W, Tsuzuki S, Hirashima J, Takeuchi Y, Oda F, Maeda M, Fukuda H. Safety monitoring of Bivalent, Quadrivalent, and 9-valent Human Papillomavirus Vaccination in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) Study. Human Vaccines & Immunotherapeutics 2026; in press.

長崎大学チームによる論文がChildrenにアクセプトされました：Maeda H*, Toizumi M, Igarashi A, Maeda M, Oda F, Fukuda H. Incidence of COVID-19-associated Hospitalization by Vaccination Status in Children and Adolescents during Omicron-dominant Period in Japan: The VENUS Study. Children 2026: 13: 183.

聖マリアンナ大学チームによる論文がVaccineにアクセプトされました：Katsuta T*, Sato S, Kawazoe Y, Fukuda H. Active vaccine safety monitoring system using health insurance claims data in Japan: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study. Vaccine 2026; in press.

長崎大学チームによる論文がVaccineにアクセプトされました：Kawazoe Y*, Katsuta T, Tanaka T, Nakamura Y, Sato S, Maeda M, Oda F, Fukuda H. Prevalence of HPV Vaccine–Associated Symptoms in Unvaccinated Japanese Adolescents: A Descriptive Study from the VENUS Study Database. Vaccine 2026; in press.

国立健康危機管理研究機構臨床研究センターチームによる論文がBMJ Public Healthにアクセプトされました：Sazawa M, Ishiguro C*, Mimura W, Maeda M, Murata F, Fukuda H. Impact of the resumption of proactive recommendation of HPV vaccination on HPV vaccination rates in Japan: An interrupted time series analysis based on the VENUS Study. BMJ Public Health 2026; in press.

国立健康危機管理研究機構 臨床研究センターチームによる論文がHuman Vaccines & Immunotherapeuticsにアクセプトされました：Ishiguro C*, Mimura W, Oda F, Maeda M, Fukuda H. Population-Based Cohort Study Assessing the Effectiveness of Maternal BNT162b2/mRNA-1273 Vaccination Against Infant Coronavirus Disease 2019 Outcomes During Omicron Predominance: The VENUS Study . Human Vaccines & Immunotherapeutics 2026; in press.

九州大学チームによる論文がBMJ Public Healthにアクセプトされました：Maeda M, Murata F, Fukuda H*. Effects of the introduction of a routine rotavirus vaccination program on vaccination coverage and factors in a Japanese municipality: The VENUS Study. BMJ Public Health 2025; 3: e002149.